SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-048582
Filing Date
2023-09-18
Accepted
2023-09-18 16:16:54
Documents
15
Period of Report
2023-09-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-20230912.htm   iXBRL 8-K 84539
2 EX-2.1 hsto-ex2_1.htm EX-2.1 94264
3 EX-99.1 hsto-ex99_1.htm EX-99.1 23137
4 GRAPHIC img196544735_0.jpg GRAPHIC 2092
  Complete submission text file 0000950170-23-048582.txt   351965

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20230912_lab.xml EX-101.LAB 17781
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20230912_pre.xml EX-101.PRE 11118
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20230912.xsd EX-101.SCH 2474
9 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20230912_htm.xml XML 4699
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 231261384
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences